Merck & Co., Inc.
MRK
$87.37
$1.291.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.82% | 4.10% | 6.74% | 6.51% | 7.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.82% | 4.10% | 6.74% | 6.51% | 7.15% |
| Cost of Revenue | -5.02% | -5.08% | -7.65% | -7.37% | -3.09% |
| Gross Profit | 4.00% | 7.19% | 11.93% | 11.62% | 10.89% |
| SG&A Expenses | 2.89% | 3.54% | 2.20% | 2.15% | -0.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.00% | -4.10% | -5.22% | 22.45% | 16.24% |
| Operating Income | 18.03% | 23.88% | 38.50% | -21.66% | -9.64% |
| Income Before Tax | 25.65% | 415.96% | 955.37% | 84.21% | 181.83% |
| Income Tax Expenses | 83.18% | 70.94% | 85.38% | -44.92% | -34.50% |
| Earnings from Continuing Operations | 19.39% | 652.52% | 4,444.56% | 163.21% | 340.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.00% | -30.77% | -33.33% | -15.38% | -23.08% |
| Net Income | 19.44% | 656.03% | 4,589.59% | 163.63% | 341.53% |
| EBIT | 18.03% | 23.88% | 38.50% | -21.66% | -9.64% |
| EBITDA | 17.22% | 23.06% | 33.92% | -17.14% | -7.32% |
| EPS Basic | 19.91% | 654.34% | 4,574.05% | 163.70% | 340.50% |
| Normalized Basic EPS | 21.72% | 26.56% | 40.15% | -24.07% | -13.81% |
| EPS Diluted | 20.41% | 669.06% | 4,968.12% | 165.15% | 342.38% |
| Normalized Diluted EPS | 22.01% | 26.59% | 40.16% | -24.13% | -13.89% |
| Average Basic Shares Outstanding | -0.33% | -0.14% | -0.09% | -0.16% | -0.09% |
| Average Diluted Shares Outstanding | -0.44% | -0.09% | -0.03% | -0.22% | -0.13% |
| Dividend Per Share | 5.33% | 5.41% | 5.48% | 5.56% | 5.63% |
| Payout Ratio | -0.12% | -0.86% | -0.98% | -0.60% | -0.76% |